Prevalence of Parkinson's disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group.

By de Rijk Mc, Lenore J. Launer, K. Berger, M. Breteler, Jean-François Dartigues, M. Baldereschi, Laura Fratiglioni, A. Lobo, J. Martínez-Lage, C. Trenkwalder and 1 more. Neurology, 2000

855 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/51f63bd9f40e2eab90e7e9aa22187389d6fb3943

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. P. Andlin-Sobocki
2. B. Jönsson
3. J. Olesen
4. Hans-Ulrich Wittchen
5. P. Goadsby

Citations in the corpus

• Cost of disorders of the brain in Europe (2005, background): “All reviews resulted in articles which were published early 2005 (Berr et al., 2005; Campenhausen et al., 2005; Fehm et al., 2005; Forsgren et al., 2005; Goodwin et al., 2005; Lieb et al., 2005; Paykel et al., 2005; Pini et al., 2005; Pugliatti et al., 2005; Rössler et al., 2005; Rehm et al.,…”
• LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress (2011, unknown): “Parkinson’s disease (PD) is one of the most common neurodegenerative disorders of aging, afflicting 0.9% of the population 65 years and older and increasing to 5.1% by the age of 85 (de Rijk et al., 2000).”